kabutan

TAKARA BIO, Apr-Dec (Cumulative 3Q) Net Income Loss Widens, Oct-Dec Net Income Loss Widens

Fri Feb 13, 2026 3:30 pm JST Earnings

4974 TAKARA BIO INC. 【J-GAAP】

Earnings Report

TAKARA BIO INC. <4974> [TSE Prime] announced its financial results after the market closed on February 13th (15:30). The consolidated net loss for the cumulative third quarter of the fiscal year ending March 2026 (April to December) expanded to a loss of 9.61 billion yen (compared to a loss of 1.37 billion yen in the same period last year).

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated net income for the January to March period (4Q) is expected to significant drop 74.4% from the same period last year to 0.61 billion yen.

In the most recent three-month period, from October to December (3Q), the consolidated net loss expanded to a loss of 2.70 billion yen (compared to a loss of 1.89 billion yen in the same period last year). The operating profit/loss margin drastically worsened from -19.8% in the same period last year to -26.2%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Dec, 2023 29,734 336 586 154 1.3 17.2 Feb 14, 2024 J-GAAP
Apr - Dec, 2024 29,282 -1,473 -1,255 -1,378 -11.5 ー Feb 13, 2025 J-GAAP
Apr - Dec, 2025 28,392 -4,855 -5,092 -9,619 -79.9 ー Feb 13, 2026 J-GAAP
YoY -3.0% -229.6% -305.7% -598.0% -597.7%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 25,281 1,846 2,043 528 4.4 17 May 13, 2025 J-GAAP
Oct - Mar, 2025 Guidance 23,306 -1,658 -1,915 -2,089 -17.4 0 Nov 11, 2025 J-GAAP
YoY -7.8% － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 43,505 3,003 3,405 1,480 12.3 17 May 10, 2024 J-GAAP
Mar, 2025 45,039 2,263 2,592 1,041 8.7 17 May 13, 2025 J-GAAP
Mar, 2026 Guidance 42,100 -4,000 -4,400 -9,000 -74.7 0 Nov 11, 2025 J-GAAP
YoY -6.5% － － － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2024 9,524 -1,890 -1,804 -1,891 -15.7 -19.8 Feb 13, 2025 J-GAAP
Jan - Mar, 2025 15,757 3,736 3,847 2,419 20.1 23.7 May 13, 2025 J-GAAP
Apr - Jun, 2025 9,266 -1,796 -1,838 -1,511 -12.6 -19.4 Aug 8, 2025 J-GAAP
Jul - Sep, 2025 9,528 -546 -647 -5,400 -44.9 -5.7 Nov 11, 2025 J-GAAP
Oct - Dec, 2025 9,598 -2,513 -2,607 -2,708 -22.5 -26.2 Feb 13, 2026 J-GAAP
YoY +0.8% -33.0% -44.5% -43.2% -43.2%

Related Articles